Medpace Holdings, Inc.·4

Jul 28, 5:37 PM ET

GEIGER JESSE J 4

4 · Medpace Holdings, Inc. · Filed Jul 28, 2025

Insider Transaction Report

Form 4
Period: 2025-07-24
Transactions
  • Exercise/Conversion

    Common Stock

    2025-07-24$107.93/sh+41,801$4,511,58278,304 total
  • Sale

    Common Stock

    2025-07-24$453.11/sh41,801$18,940,45136,503 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2025-07-2441,8010 total
    Exercise: $107.93Exp: 2026-02-28Common Stock (41,801 underlying)
Footnotes (3)
  • [F1]The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.
  • [F2]The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $450.039 to $457.992. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
  • [F3]The option vested in full on February 28, 2020.

Documents

1 file
  • 4
    wk-form4_1753738637.xmlPrimary

    FORM 4